Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more than 20 years.

Vertex Pharmaceuticals' newly FDA-approved non-opioid analgesic, Journavx, offers a groundbreaking alternative for managing ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

Tissue engineering is a set of methods that can replace or repair damaged or diseased tissues with natural, synthetic, or semisynthetic tissue mimics. These mimics can either be fully functional ...

Vertex AI RAG Engine is a managed orchestration service aimed to make it easier to connect large language models (LLMs) to ...

Here’s how it works. Finding the best laptop for engineering studies can sometimes be tricky, especially if the engineering department of your school has painfully specific or vague requirements ...

Get Wall Street's Hottest Chart Every Morning RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients who ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

Get inspired at a world leading Mechanical Engineering Department. Isabela shows us what it's like to be a first year student. What's it like to be a first year student in the Department of Mechanical ...

BOSTON, January 12, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the ...

Detailed price information for Vertex Resource Group Ltd (VTX-X) from The Globe and Mail including charting and trades.

Duke’s Pratt School of Engineering is dedicated to educating the engineering leaders needed to tackle the world’s toughest problems while making a positive impact on those around us. Detailed within ...